Assenagon Asset Management S.A. Purchases Shares of 640,760 Oscar Health, Inc. $OSCR

Assenagon Asset Management S.A. bought a new stake in Oscar Health, Inc. (NYSE:OSCR) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 640,760 shares of the company’s stock, valued at approximately $9,208,000. Assenagon Asset Management S.A. owned approximately 0.24% of Oscar Health as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently bought and sold shares of the stock. Straightline Group LLC lifted its position in shares of Oscar Health by 3.7% in the second quarter. Straightline Group LLC now owns 18,082 shares of the company’s stock worth $388,000 after purchasing an additional 640 shares in the last quarter. OneDigital Investment Advisors LLC grew its position in Oscar Health by 0.6% during the third quarter. OneDigital Investment Advisors LLC now owns 138,271 shares of the company’s stock valued at $2,617,000 after purchasing an additional 779 shares in the last quarter. Focus Partners Wealth increased its stake in Oscar Health by 1.4% in the 3rd quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after buying an additional 824 shares during the period. PNC Financial Services Group Inc. increased its stake in Oscar Health by 14.4% in the 2nd quarter. PNC Financial Services Group Inc. now owns 7,140 shares of the company’s stock valued at $153,000 after buying an additional 900 shares during the period. Finally, Binnacle Investments Inc lifted its position in Oscar Health by 28.6% in the 3rd quarter. Binnacle Investments Inc now owns 4,500 shares of the company’s stock worth $85,000 after buying an additional 1,000 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

OSCR has been the topic of several research analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a report on Thursday, January 22nd. Stephens assumed coverage on Oscar Health in a report on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price objective for the company. UBS Group reissued a “neutral” rating and set a $15.00 price objective on shares of Oscar Health in a research report on Wednesday, February 11th. Raymond James Financial upgraded Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a research note on Thursday, February 12th. Finally, Wall Street Zen raised Oscar Health from a “sell” rating to a “hold” rating in a research report on Saturday, February 14th. Two analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $16.88.

Insiders Place Their Bets

In related news, insider Mario Schlosser sold 23,038 shares of the firm’s stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $17.65, for a total transaction of $406,620.70. Following the completion of the transaction, the insider owned 350,180 shares in the company, valued at $6,180,677. This trade represents a 6.17% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 24.39% of the company’s stock.

Oscar Health Trading Down 5.7%

Shares of OSCR stock opened at $11.16 on Friday. The firm has a fifty day moving average of $13.64 and a 200-day moving average of $16.12. The stock has a market cap of $3.32 billion, a price-to-earnings ratio of -6.41 and a beta of 1.91. Oscar Health, Inc. has a 52-week low of $11.05 and a 52-week high of $23.80. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.96 and a current ratio of 0.96.

Oscar Health (NYSE:OSCR) last posted its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative net margin of 3.79% and a negative return on equity of 39.35%. The business had revenue of $2.81 billion during the quarter, compared to the consensus estimate of $3.12 billion. During the same period in the previous year, the firm earned ($0.62) EPS. The business’s revenue was up 17.3% compared to the same quarter last year. On average, equities research analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.